Emerald Health Therapeutics Inc
F:TBD
Emerald Health Therapeutics Inc
F:TBD
Price:
0.016
EUR
Market Cap:
€6.6m
Cash Flow Statement
Cash Flow Statement
Emerald Health Therapeutics Inc
Emerald Health Therapeutics Inc
Currency: CAD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(147)
|
(44)
|
(42)
|
(37)
|
(34)
|
(39)
|
(40)
|
(28)
|
|
| Depreciation & Amortization |
10
|
5
|
4
|
4
|
3
|
3
|
2
|
1
|
|
| Change in Deffered Taxes |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
91
|
22
|
22
|
15
|
14
|
26
|
27
|
16
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Change in Working Capital |
17
|
6
|
1
|
2
|
(4)
|
(7)
|
(2)
|
1
|
|
| Cash from Operating Activities |
(30)
N/A
|
(11)
+65%
|
(14)
-33%
|
(16)
-12%
|
(20)
-29%
|
(17)
+16%
|
(13)
+25%
|
(10)
+24%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(29)
|
(4)
|
(5)
|
(4)
|
(4)
|
(1)
|
0
|
0
|
|
| Other Items |
(18)
|
59
|
71
|
71
|
71
|
21
|
9
|
9
|
|
| Cash from Investing Activities |
(46)
N/A
|
54
N/A
|
67
+22%
|
67
+0%
|
67
+1%
|
20
-71%
|
9
-55%
|
10
+8%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
30
|
6
|
5
|
1
|
1
|
1
|
0
|
0
|
|
| Net Issuance of Debt |
21
|
(25)
|
(25)
|
(25)
|
(25)
|
(1)
|
(1)
|
(0)
|
|
| Other |
(10)
|
(1)
|
(1)
|
(1)
|
(1)
|
(11)
|
(11)
|
(11)
|
|
| Cash from Financing Activities |
41
N/A
|
(20)
N/A
|
(22)
-7%
|
(25)
-15%
|
(25)
0%
|
(10)
+60%
|
(11)
-14%
|
(11)
+1%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
(36)
N/A
|
23
N/A
|
31
+31%
|
26
-16%
|
22
-16%
|
(7)
N/A
|
(15)
-104%
|
(11)
+25%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(58)
N/A
|
(15)
+74%
|
(19)
-26%
|
(20)
-6%
|
(24)
-22%
|
(18)
+26%
|
(13)
+30%
|
(9)
+26%
|
|
Switch to:
Switch to:
See Also
Discover More
